The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile-Reference-Cited by-同舟云学术

The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile

Published:2008-11-21 Issue:16 Volume:23 Page:2398-2403
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Goetz Christopher G.,Nutt John G.,Stebbins Glenn T.

Funder

Michael J. Fox Foundation

EMD/Merck KGaA Pharmaceuticals

Parkinson's Disease Foundation Research Center

National Parkinson Disease Center of Excellence

NIH

Biogen Boehringer-Ingelheim

Ceregene

EMD Pharmaceuticals

Impax

I3 Research

Juvantia

Kiowa

GlaxoSmith Kline

Merck KGaA

Merck and Co.

Neurim

Novartis

Ovation

Oxford Biomedica

Schering-Plough

Solstice Neuroscience

Solvay

Synergy/Intec

Teva Pharmaceuticals

Fragile X Foundation

Kinetics Foundation

Kinetics Fdn

National Parkinson Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.22341/fullpdf

Reference24 articles.

1. Levodopa-induced dyskinesias;Fabbrini;Mov Disord,2007

2. Motor fluctuations and dyskinesias in Parkinson's disease;Nutt;Parkkinsonism Relat Disord,2001

3. Drug insight: new drugs in development for Parkinson's disease;Colosimo;Nat Clin Pract Neurol,2006

4. Pathophysiology of levodopa-induced dyskinesia: potential or new therapies;Bézard;Nat Rev Neurosci,2001

5. Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease;Rascol;Mov Disord,2001

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automatic two-dimensional & three-dimensional video analysis with deep learning for movement disorders: A systematic review;Artificial Intelligence in Medicine;2024-10

2. Brain and muscles magnetic stimulation in a drug-free case of Parkinson’s disease: Motor improvements concomitant to neuroplasticty;Heliyon;2024-08

3. Efficacy and safety of Tianqi Pingchan Granule, a compound Chinese herbal medicine, for levodopa-induced dyskinesia in Parkinson’s disease: A randomized double-blind placebo-controlled trial;Journal of Integrative Medicine;2024-07

4. Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion;Movement Disorders Clinical Practice;2024-06-24

5. Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia;Neuropharmacology;2024-05